ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 280 filers reported holding ICU MED INC in Q4 2020. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $189,107 | -38.3% | 1,589 | -7.7% | 0.00% | – |
Q2 2023 | $306,665 | -4.4% | 1,721 | -11.5% | 0.00% | -100.0% |
Q1 2023 | $320,682 | -4.7% | 1,944 | -9.0% | 0.00% | 0.0% |
Q4 2022 | $336,377 | -1.6% | 2,136 | -6.1% | 0.00% | 0.0% |
Q3 2022 | $342,000 | -32.5% | 2,275 | -26.3% | 0.00% | 0.0% |
Q2 2022 | $507,000 | -16.3% | 3,087 | +13.3% | 0.00% | 0.0% |
Q1 2022 | $606,000 | -19.0% | 2,725 | -13.6% | 0.00% | 0.0% |
Q4 2021 | $748,000 | -1.8% | 3,155 | -3.3% | 0.00% | 0.0% |
Q3 2021 | $762,000 | +2.1% | 3,264 | -9.9% | 0.00% | 0.0% |
Q2 2021 | $746,000 | +11.3% | 3,622 | +10.9% | 0.00% | 0.0% |
Q1 2021 | $670,000 | -17.2% | 3,267 | -13.3% | 0.00% | -50.0% |
Q4 2020 | $809,000 | +1.9% | 3,769 | -13.3% | 0.00% | 0.0% |
Q3 2020 | $794,000 | -15.0% | 4,348 | -14.2% | 0.00% | 0.0% |
Q2 2020 | $934,000 | -18.5% | 5,067 | -10.9% | 0.00% | -50.0% |
Q1 2020 | $1,146,000 | -3.2% | 5,685 | -10.2% | 0.00% | +33.3% |
Q4 2019 | $1,184,000 | -1.2% | 6,328 | -15.7% | 0.00% | 0.0% |
Q3 2019 | $1,198,000 | -43.8% | 7,508 | -11.3% | 0.00% | -50.0% |
Q2 2019 | $2,133,000 | -2.1% | 8,469 | -7.0% | 0.01% | 0.0% |
Q1 2019 | $2,178,000 | +4.1% | 9,103 | -0.2% | 0.01% | -14.3% |
Q4 2018 | $2,092,000 | -23.4% | 9,117 | -5.6% | 0.01% | -12.5% |
Q3 2018 | $2,732,000 | -4.4% | 9,661 | -0.8% | 0.01% | -11.1% |
Q2 2018 | $2,859,000 | +8.3% | 9,736 | -7.0% | 0.01% | +12.5% |
Q1 2018 | $2,641,000 | +3.4% | 10,468 | -11.4% | 0.01% | 0.0% |
Q4 2017 | $2,554,000 | -0.4% | 11,821 | -14.3% | 0.01% | 0.0% |
Q3 2017 | $2,565,000 | -5.3% | 13,799 | -12.1% | 0.01% | -11.1% |
Q2 2017 | $2,708,000 | +18.0% | 15,705 | +4.5% | 0.01% | +12.5% |
Q1 2017 | $2,295,000 | +20.6% | 15,035 | +16.5% | 0.01% | +14.3% |
Q4 2016 | $1,903,000 | +14.6% | 12,911 | -1.7% | 0.01% | +16.7% |
Q3 2016 | $1,660,000 | +83.8% | 13,137 | +63.9% | 0.01% | +100.0% |
Q2 2016 | $903,000 | -2.8% | 8,014 | -10.3% | 0.00% | -25.0% |
Q1 2016 | $929,000 | -16.9% | 8,930 | -9.9% | 0.00% | 0.0% |
Q4 2015 | $1,118,000 | +0.2% | 9,911 | -2.8% | 0.00% | -20.0% |
Q3 2015 | $1,116,000 | -0.9% | 10,197 | -13.3% | 0.01% | +25.0% |
Q2 2015 | $1,126,000 | +7.6% | 11,768 | +4.8% | 0.00% | 0.0% |
Q1 2015 | $1,046,000 | +15.6% | 11,228 | +1.6% | 0.00% | +33.3% |
Q4 2014 | $905,000 | -4.9% | 11,051 | -25.5% | 0.00% | -25.0% |
Q3 2014 | $952,000 | +2.0% | 14,829 | -3.3% | 0.00% | 0.0% |
Q2 2014 | $933,000 | +5.4% | 15,333 | +3.7% | 0.00% | 0.0% |
Q1 2014 | $885,000 | -7.0% | 14,793 | -1.0% | 0.00% | 0.0% |
Q4 2013 | $952,000 | -27.2% | 14,944 | -22.3% | 0.00% | -33.3% |
Q3 2013 | $1,307,000 | -12.5% | 19,222 | -7.3% | 0.01% | -14.3% |
Q2 2013 | $1,494,000 | – | 20,730 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EVR Research LP | 22,000 | $4,719,000 | 3.86% |
NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |